Close
The page header's logo
Help
Login
Staff Login
Register
FR
0
Selected 
Invert selection
Deselect all
Deselect all
 Add to Cart
 Click here to refresh results
 Click here to refresh results
Go to Login page
 Hide details
doctype icon
Conceptually similar
WHO: Ethical to use untested Ebola drugs
play button
CP13425220 | WHO: Ethical to use untested Ebola drugs 
Ebola patient received experimental drug
play button
CP13428506 | Ebola patient received experimental drug 
Ebola patient received experimental drug
play button
CP13428811 | Ebola patient received experimental drug 
WHO lauds new experimental Ebola vaccine trial
play button
CP13429331 | WHO lauds new experimental Ebola vaccine trial 
Experimental Alzheimer's Drug Shows Some Benefit
play button
CP13370196 | Experimental Alzheimer's Drug Shows Some Benefit 
Nebraska hospital to treat a 2nd Ebola patient
play button
CP13431189 | Nebraska hospital to treat a 2nd Ebola patient 
FDA to improve access to experimental cancer drugs
Mp4
play button
CP12039606 | FDA to improve access to experimental cancer drugs 
WHO: Ebola vaccine trials to start a in January
play button
CP13429108 | WHO: Ebola vaccine trials to start a in January 
Nurse who survived Ebola virus to file lawsuit
play button
CP13219022 | Nurse who survived Ebola virus to file lawsuit 
AP gets rare access to Israeli skylark drone
play button
CP13413335 | AP gets rare access to Israeli skylark drone 
Action button

Ebola: Who gets access to experimental drug

The use of an experimental drug to treat two Americans and a Spaniard diagnosed with Ebola is raising ethical questions about who gets first access to unproven new therapies. AP medical writer Lauran Neergaard takes a closer look. (Aug. 11)
Video provided by AP 
Actions
 Add to collection
 Add to cart
Information
Source name: 
The Associated Press
Unique identifier: CP13424916 
Legacy Identifier: 15059c1ace4d4be29be5a85bbfd63376 
Type: Video 
Duration: 51s 
Dimensions: 854px × 480px     11.35 MB 
Usage rights: Digital platform use only. Broadcast rights and editing of content prohibited. 
Create Date: 8/12/2014 2:25:24 AM 
Display aspect ratio: 427:240